|
|
|
| Editorial Board: |
Praveen Anand |
Imperial College London, London, UK
|
|
Corrado Angelini |
University of Padova, Italy
|
|
Kailash Bhatia |
University College London, London, UK
|
|
Ingmar Blümcke |
University Hospital Erlangen, Erlangen, Germany
|
|
Wolfgang Brück |
University of Goettingen, Goettingen, Germany
|
|
Hans-Christoph Diener |
University Essen, Germany
|
|
Peter Goadsby |
Institute of Neurology, London, UK
|
|
Hans-Peter Hartung |
Heinrich-Heine University, Düsseldorf, Germany
|
|
Reinhard Hohlfeld |
Institute for Clinical Neuroimmunology, Munich, Germany
|
|
Ryuji Kaji |
Tokushima University Graduate School of Medicine, Tokushima, Japan
|
|
Michael Kaplitt |
Weill Medical College of Cornell University, New York, NY, USA
|
|
Trevor Kilpatrick |
University of Melbourne, Australia
|
|
Frank L. Mastaglia |
University of Western Australia, Perth, WA, Australia
|
|
Xavier Montalban |
Hospital Universitari Vall d'Hebron, Spain
|
|
Ichizo Nishino |
National Center of Neurology and Psychiatry, Tokyo, Japan
|
|
Michael K. Racke |
The Ohio State University Medical Center, Columbus, OH, USA
|
|
Peter Rieckmann |
University of Vancouver, Vancouver, BC, Canada
|
|
Felix Rosenow |
University of Marburg, Marburg, Germany
|
|
Uwe Schlegel |
Ruhr-University Bochum, Germany
|
|
Graeme Sills |
Liverpool University, Liverpool, UK
|
|
Per Soelberg Sørensen |
Copenhagen University Hospital, Copenhagen, Denmark
|
|
Klaus V Toyka |
Universität Würzburg, Würzburg, Germany
|
|
Eugen Trinka |
Medical University Innsbruck, Austria
|
|
Takashi Yamamura |
National Institute of Neuroscience, Tokyo, Japan
|